Research on lifestyle programs for patients with coronary artery disease (CAD) has largely recruited from hospitals and/or recruited following acute coronary syndrome. By contrast, this study evaluated a 3-session behavioral health program for patients with stable CAD treated in an outpatient cardiology clinic. Thirty-three patients were randomized to the behavioral lifestyle intervention or to Treatment as Usual (TAU). A priori feasibility and acceptability criteria were met, and reliable change analyses revealed that at post-treatment and 30-day follow-up, significantly more intervention participants than TAU participants exhibited increased self-efficacy compared with baseline.
AjzenIMaddenTJ (1986) Prediction of goal-directed behavior: Attitudes, intentions, and perceived behavioral control. Journal of Experi-mental Social Psychology22(5): 453–474.
2.
ArnettDKBlumenthalRSAlbertMA, et al. (2019) 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology74(10): 1376–1414.
3.
BaladyGJAdesPABittnerVA, et al. (2011) Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: A presidential advisory from the American Heart Association. Circulation124(25): 2951–2960.
4.
BanduraA (1977) Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review84(2): 191–215.
5.
BillingsJH (2000) Maintenance of behavior change in cardiorespiratory risk reduction: A clinical perspective from the Ornish program for reversing coronary heart disease. Health Psychology19(Suppl 1): 70–75.
6.
BlackJLAllisonTGWilliamsDE, et al. (1998) Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients. Psychosomatics39(2): 134–143.
7.
BlumenthalJASherwoodASmithPJ, et al. (2016) Enhancing cardiac rehabilitation with stress management training: A randomized, clinical efficacy trial. Circulation133(14): 1341–1350.
8.
BosworthHBBlalockDVHoyleRH, et al. (2018) The role of psychological science in efforts to improve cardiovascular medication adherence. American Psychologist73(8): 968–980.
9.
BraunwaldEDomanskiMJFowlerSE, et al. (2004) Angiotensin-converting-enzyme inhibition in stable coronary artery disease. The New England Journal of Medicine351(20): 2058–2068.
10.
BroadbentEPetrieKJMainJ, et al. (2006) The brief illness perception questionnaire. Journal of Psychosomatic Research60(6): 631–637.
11.
BuschAMWagenerTLGregorKL, et al. (2011) Utilizing reliable and clinically significant change criteria to assess for the development of depression during smoking cessation treatment: The importance of tracking idiographic change. Addictive Behaviors36(12): 1228–1232.
12.
CarneyRMBlumenthalJAFreedlandKE, et al. (2004) Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study. Psychosomatic Medicine66(4): 466–474.
13.
CullyJAStanleyMAPetersenNJ, et al. (2017) Delivery of brief cognitive behavioral therapy for medically ill patients in primary care: A pragmatic randomized clinical trial. Journal of General Internal Medicine32(9): 1014–1024.
14.
DornelasEASearsSF (2018) Living with heart despite recurrent challenges: Psychological care for adults with advanced cardiac disease. American Psychologist73(8): 1007–1018.
15.
FihnSDGardinJMAbramsJ, et al. (2012) 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. Journal of the American College of Cardiology60(24): e44–e164.
16.
FoxKM and EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet362(9386): 782–788.
17.
HallMHBrindleRCBuysseDJ (2018) Sleep and cardiovascular disease: Emerging opportunities for psychology. American Psychologist73(8): 994–1006.
18.
HortonRRockerGDaleA, et al. (2013) Implementing a palliative care trial in advanced COPD: A feasibility assessment (The COPD IMPACT Study). Journal of Palliative Medicine16(1): 67–73.
19.
HundtNERennBNSansgiryS, et al. (2018) Predictors of response to brief CBT in patients with cardiopulmonary conditions. Health Psychology37(9): 866–873.
20.
IversonGL (2018) Reliable change index. In: KreutzerJSDeLucaJCaplanB (eds) Encyclopedia of Clinical Neuropsychology. New York; London: Springer International Publishing, AG, part of Springer Nature, pp. 2984–2987.
21.
JacobsonNSTruaxP (1991) Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology59(1): 12–19.
22.
JanssenVde GuchtVvan ExelH, et al. (2013) Changes in illness perceptions and quality of life during participation in cardiac rehabilitation. International Journal of Behavioral Medicine20(4): 582–589.
23.
JhamnaniSPatelDHeimlichL, et al. (2015) Meta-analysis of the effects of lifestyle modifications on coronary and carotid atherosclerotic burden. The American Journal of Cardiology115(2): 268–275.
24.
JonesTAOldsTSCurrowDC, et al. (2017) Feasibility and pilot studies in palliative care research: A systematic review. Journal of Pain and Symptom Management54(1): 139–151.
25.
KoertgeJWeidnerGElliott-EllerM, et al. (2003) Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project. The American Journal of Cardiology91(11): 1316–1322.
26.
KroenkeKSpitzerRLWilliamsJBW (2001) The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine16(9): 606–613.
27.
LauzonCBeckCAHuynhT, et al. (2003) Depression and prognosis following hospital admission because of acute myocardial infarction. Canadian Medical Association Journal168(5): 547–552.
28.
LesperanceFFrasure-SmithNTalajicM (1996) Major depression before and after myocardial infarction: Its nature and consequences. Psychosomatic Medicine58(2): 99–110.
29.
LisspersJSundinÖHofman-BangC, et al. (1999) Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: A prospective, randomized, controlled study. Journal of Psychosomatic Research46(2): 143–154.
30.
LorigKRSobelDSRitterPL, et al. (2001) Effect of a self-management program on patients with chronic disease. Effective Clinical Practice4(6): 256–262.
31.
MayouRAThompsonDRClementsA, et al. (2002) Guideline-based early rehabilitation after myocardial infarction: A pragmatic randomized controlled trial. Journal of Psychosomatic Research52(2): 89–95.
32.
McLaughlinTJAupontOBambauerKZ, et al. (2005) Improving psychologic adjustment to chronic illness in cardiac patients: The role of depression and anxiety. Journal of General Internal Medicine20(12): 1084–1090.
33.
ProchaskaJOVelicerWF (1997) The transtheoretical model of health behavior change. American Journal of Health Promotion12(1): 38–48.
34.
RitterPLLorigK (2014) The English and Spanish self-efficacy to manage chronic disease scale measures were validated using multiple samples. Journal of Clinical Epidemiology67(11): 1265–1273.
35.
RozanskiA (2014) Behavioral cardiology: Current advances and future directions. Journal of the American College of Cardiology64(1): 100–110.
36.
SheeranPMakiAMontanaroE, et al. (2016) The impact of changing attitudes, norms, and self-efficacy on health-related intentions and behavior: A meta-analysis. Health Psychology35(11): 1178–1188.
37.
SmithSCBenjaminEJBonowRO, et al. (2011) AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation. Circulation124(22): 2458–2473.
38.
SpitzerRLKroenkeKWilliamsJBW, et al. (2006) A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine166(10): 1092–1097.
39.
ThombsBDBassEBFordDE, et al. (2005) Prevalence of depression in survivors of acute myocardial infarction: Review of the evidence. Journal of General Internal Medicine21(1): 30–38.
40.
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2017) Heart disease facts. Available at: https://www.cdc.gov/heartdisease/facts.htm (accessed 27 December 2017).
41.
U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute (2013) Managing overweight and obesity in adults: Systematic evidence review from the obesity expert panel. Available at: https://www.nhlbi.nih.gov/sites/default/files/media/docs/obesity-evidence-review.pdf (accessed 30 March 2018).
42.
WhalleyBThompsonDRTaylorRS (2014) Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. International Journal of Behavioral Medicine21(1): 109–121.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
